Skip to main content

Table 1 PDCD2L expression and its association with clinicopathological features of CRC

From: Pan-cancer analysis of oncogenic role of Programmed Cell Death 2 Like (PDCD2L) and validation in colorectal cancer

 

low-PDCD2L

high-PDCD2L

 

Characteristics

No.(%)

No.(%)

P value

Age(years)

  

0.083

Mean ± SD

56.2 ± 14.1

59.4 ± 12.2

 

 < 60

45(60.8)

39(47.0)

 

 ≥ 60

29(39.2)

44(53.0)

 

Sex

  

0.002

 Male

56(75.7)

43(51.8)

 

 Female

18(24.3)

40(48.2)

 

Tumor size(cm)

  

0.519

 Mean ± SD

4.9 ± 2.4

4.2 ± 1.5

 

  < 5

42(58.3)

52(63.4)

 

  ≥ 5

30(41.7)

30(36.6)

 

Histological differentiation

  

0.041

 Poorly

18(24.7)

10(12.0)

 

 Moderately and well

55(75.3)

73(88.0)

 

T classification

  

0.332

 T1 + T2

10(13.5)

16(19.3)

 

 T3 + T4

64(86.5)

67(80.7)

 

N classification

  

0.585

 N0

36(48.6)

44(53.0)

 

 N1 + N2

38(51.4)

39(47.0)

 

M classification

  

0.851

 M0

69(93.2)

78(94.0)

 

 M1

5(6.8)

5(6.0)

 

TNM stage

  

0.463

 I + II

34(45.9)

43(51.8)

 

 III + IV

40(54.1)

40(48.2)

 

Vascular tumor thrombus

  

0.56

 Absent

64(86.5)

69(83.1)

 

 Present

10(13.5)

14(16.9)

 

Perineural invasion

  

0.734

 Absent

57(77.0)

62(74.7)

 

 Present

17(23.0)

21(25.3)